This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Belanger, A. E.
Right arrow Articles by LeBlanc, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Belanger, A. E.
Right arrow Articles by LeBlanc, D. J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2002, p. 2507-2512, Vol. 46, No. 8
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.8.2507-2512.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

PCR-Based Ordered Genomic Libraries: a New Approach to Drug Target Identification for Streptococcus pneumoniae

Aimee E. Belanger,* Angel Lai, Marcia A. Brackman, and Donald J. LeBlanc,{dagger}

Infectious Disease Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285

Received 7 February 2002/ Returned for modification 1 April 2002/ Accepted 17 May 2002

Described here are the development and validation of a novel approach to identify genes encoding drug targets in Streptococcus pneumoniae. The method relies on the use of an ordered genomic library composed of PCR amplicons that were generated under error-prone conditions so as to introduce random mutations into the DNA. Since some of the mutations occur in drug target-encoding genes and subsequently affect the binding of the drug to its respective cellular target, amplicons containing drug targets can be identified as those producing drug-resistant colonies when transformed into S. pneumoniae. Examination of the genetic content of the amplicon giving resistance coupled with bioinformatics and additional genetic approaches could be used to rapidly identify candidate drug target genes. The utility of this approach was verified by using a number of known antibiotics. For drugs with single protein targets, amplicons were identified that rendered S. pneumoniae drug resistant. Assessment of amplicon composition revealed that each of the relevant amplicons contained the gene encoding the known target for the particular drug tested. Fusidic acid-resistant mutants that resulted from the transformation of S. pneumoniae with amplicons containing fusA were further characterized by sequence analysis. A single mutation was found to occur in a region of the S. pneumoniae elongation factor G protein that is analogous to that already implicated in other bacteria as being associated with fusidic acid resistance. Thus, in addition to facilitating the identification of genes encoding drug targets, this method could provide strains that aid future mechanistic studies.

* Corresponding author. Mailing address: Infectious Disease Research, Lilly Research Laboratories, Eli Lilly and Company, Drop Code 0428, Indianapolis, IN 46285. Phone: (317) 276-1040. Fax: (317) 277-0778. E-mail: Belanger_Aimee{at}Lilly.com.

{dagger} Present address: Pharmacia Corporation, Kalamazoo, MI 49001.

Antimicrobial Agents and Chemotherapy, August 2002, p. 2507-2512, Vol. 46, No. 8
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.8.2507-2512.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Miller, A. A., Bundy, G. L., Mott, J. E., Skepner, J. E., Boyle, T. P., Harris, D. W., Hromockyj, A. E., Marotti, K. R., Zurenko, G. E., Munzner, J. B., Sweeney, M. T., Bammert, G. F., Hamel, J. C., Ford, C. W., Zhong, W.-Z., Graber, D. R., Martin, G. E., Han, F., Dolak, L. A., Seest, E. P., Ruble, J. C., Kamilar, G. M., Palmer, J. R., Banitt, L. S., Hurd, A. R., Barbachyn, M. R. (2008). Discovery and Characterization of QPT-1, the Progenitor of a New Class of Bacterial Topoisomerase Inhibitors. Antimicrob. Agents Chemother. 52: 2806-2812 [Abstract] [Full Text]  
  • Brotherton, P., Endicott, P., Sanchez, J. J., Beaumont, M., Barnett, R., Austin, J., Cooper, A. (2007). Novel high-resolution characterization of ancient DNA reveals C > U-type base modification events as the sole cause of post mortem miscoding lesions. Nucleic Acids Res 35: 5717-5728 [Abstract] [Full Text]  
  • Ferrandiz, M. J., Perez-Trallero, E., Marimon, J. M., de la Campa, A. G. (2005). Clinical Isolates of the Spain14-5 Clone of Streptococcus pneumoniae Carry a Recombinant rpoB Gene. Antimicrob. Agents Chemother. 49: 4811-4813 [Full Text]  
  • Lerner, C. G., Kakavas, S. J., Wagner, C., Chang, R. T., Merta, P. J., Ruan, X., Metzger, R. E., Beutel, B. A. (2005). Novel Approach to Mapping of Resistance Mutations in Whole Genomes by Using Restriction Enzyme Modulation of Transformation Efficiency. Antimicrob. Agents Chemother. 49: 2767-2777 [Abstract] [Full Text]  
  • Belanger, A. E., Clague, M. J., Glass, J. I., LeBlanc, D. J. (2004). Pyruvate Oxidase Is a Determinant of Avery's Rough Morphology. J. Bacteriol. 186: 8164-8171 [Abstract] [Full Text]  
  • Martin-Galiano, A. J., de la Campa, A. G. (2003). High-Efficiency Generation of Antibiotic-Resistant Strains of Streptococcus pneumoniae by PCR and Transformation. Antimicrob. Agents Chemother. 47: 1257-1261 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»